Scienmag
OCTOBER 26, 2020
NIA experts available to share context and insight on latest research shared at CTAD WHAT: National Institute on Aging (NIA) experts will be available to further explain and analyze some of the latest research as presented at the 13th Annual International Conference on Clinical Trials for Alzheimer’s Disease (CTAD).
Clinical Trial Podcast
AUGUST 24, 2023
She has over 20 years of research/ R&D experience, serving in roles such as Vice President Research, Senior Managing Director, Director Clinical Trials Office, Director of Clinical Research, Interim Executive Director, Clinical Trials Office and Director of Research Operations. Erika holds her B.A.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
OCTOBER 21, 2020
While FDA-approved technique is used to treat other medical conditions, this study examines its effects on cognitive function Credit: Image courtesy of Ricardo Carrasco III of Keck Medicine of USC LOS ANGELES — An estimated 5.5 million people in the United States live with Alzheimer’s disease, which is the most common form of dementia.
pharmaphorum
NOVEMBER 22, 2021
In late 2006, BRAVEMIND was tested in San Diego, California, at the Naval Medical Center and Camp Pendleton, and good clinical data was obtained in the initial open clinical trials. Other groups started to adopt the platform, which led to more research as to its clinical efficacy. VR clinical trials.
Scienmag
MAY 16, 2021
NIH-funded clinical trial improved frailty, depression and overall quality of life An innovative cardiac rehabilitation intervention started earlier and more custom-tailored to the individual improved physical function, frailty, quality-of-life, and depression in hospitalized heart failure patients, compared to traditional rehabilitation programs.
Scienmag
APRIL 20, 2021
Listening to music before going to be can improve sleep quality among older adults, according to an analysis of all relevant published clinical trials. In the analysis, which is published in the Journal of the American Geriatrics Society, five randomized trials met the investigators’ criteria.
Scienmag
MARCH 24, 2021
Clinical trial participants saw memory-enhancing benefits and disease modifying activities when taking Sargramostim A new study suggests that Sargramostim, a medication often used to boost white blood cells after cancer treatments, is also effective in treating and improving memory in people with mild-to-moderate Alzheimer’s disease.
Expert insights. Personalized for you.
73 
Let's personalize your content